| |
Newsroom /
Industry
/
Industry
/
Biobanks - 2011 Yearbook
Biobanks - 2011 Yearbook
Fostering Drug Discovery with the Significant Increase in the Number of Biobanks During 1970-2010
London,
London,
United Kingdom
(prbd.net)
02/03/2011
Biobanks have recently been developed under the support of public or private initiatives as suitable tools for biomedical research purposes. The number of biobanks significantly increased during 1989-1999, with significant percentage increase in the 1990s. The majority of biobanks are formed as an integral part of a university to facilitate research and also to provide samples to external researchers. This report provides in-depth study of 40 major biobanks, with analysis of biobanking funding structure and volume of sample sizes in the biobanks, with a major focus on issues concerning biobanks.
For Sample Pages, please click or add the below link to your browser:
http://www.gbiresearch.com/RequestSamplePages.aspx?ID=Biobanks-2011-Yearbook&Title=Pharmaceuticals_and_Healthcare&ReportType=Industry_Report
The availability of a specific type of sample and a particular mode of storage are some of the common issues in biobanks. A tumor tissue repository (TTR) is a source of brain tumor samples, which suffers from the problem of the unavailability of normal brain samples to use as controls during studies. The situation is similar in other types of biobank. Comparative studies are increasingly difficult due to the unavailability of negative samples such as controls.
Sample storage also plays a vital role in each biobank. Among the various ways to store tissue, such as formalin fixed, paraffin embedded blocks and snap frozen samples, frozen tissue is always in significant demand and so preserving tissue via this method is popular.
In a comparative study of more than 100 biobanks around the world, many biobanks are found to be stand-alone, with the whole funding received by the government of the country. Around 70% of biobanks are stand-alone, whereas only 30% are partnered with other biobanks or institutions.
GBI Research, the leading business intelligence provider, has released its latest research, “Biobanks – 2011 Yearbook”. It provides key data, information and analysis of the 40 major biobanks in the world. The report provides information on the population-based biobanks, disease based biobanks, brain biobanks, stem cell biobanking, twin registries, children biobanks and many national biobanks. This report provides comprehensive analysis of funding, harmonization, cost of biobanking, and partnership structure. It also reviews the factors determining the success and failure of the biobanks.
It is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GBI Research’s team of industry experts
For further details, please click or add the below link to your browser:
http://www.gbiresearch.com/Report.aspx?ID=Biobanks-2011-Yearbook&ReportType=Industry_Report&coreindustry=ALL&Title=Pharmaceuticals_and_Healthcare
Visit our report store: http://www.gbiresearch.com
For more details contact:
pressreleases@gbiresearch.com
North America: +1 646 395 5477
Europe: +44 207 753 4299
+44 1204 543 533
Asia Pacific: +91 40 6616 6782
About
GBI Research is a global market intelligence services company providing information research and analysis products and services.
|